200,000+ products from a single source!
sales@angenechem.com
CAS No: 101-26-8 Catalog No: AG0033GW MDL No:MFCD00079283
| Title | Journal |
|---|---|
| Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness. | Toxicology and applied pharmacology 20180701 |
| Zebrafish is a predictive model for identifying compounds that protect against brain toxicity in severe acute organophosphorus intoxication. | Archives of toxicology 20170101 |
| Chronic Oxidative Stress, Mitochondrial Dysfunction, Nrf2 Activation and Inflammation in the Hippocampus Accompany Heightened Systemic Inflammation and Oxidative Stress in an Animal Model of Gulf War Illness. | Frontiers in molecular neuroscience 20170101 |
| Exposure to Gulf War Illness chemicals induces functional muscarinic receptor maladaptations in muscle nociceptors. | Neurotoxicology 20160501 |
| Gulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War Illness. | PloS one 20150101 |
| Persistent modification of Nav1.9 following chronic exposure to insecticides and pyridostigmine bromide. | Toxicology and applied pharmacology 20140615 |
| Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. | Disease models & mechanisms 20121101 |
| Autonomic nervous system modulation affects the inflammatory immune response in mice with acute Chagas disease. | Experimental physiology 20121101 |
| Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. | Multiple sclerosis (Houndmills, Basingstoke, England) 20120801 |
| Myasthenia gravis and endurance exercise. | American journal of physical medicine & rehabilitation 20120801 |
| Gulf War illnesses are autoimmune illnesses caused by reactive oxygen species which were caused by nerve agent prophylaxis. | Medical hypotheses 20120801 |
| A prospective, 1-year follow-up study of postural tachycardia syndrome. | Mayo Clinic proceedings 20120801 |
| Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury. | Toxicology and applied pharmacology 20120715 |
| Prolonged release matrix tablet of pyridostigmine bromide: formulation and optimization using statistical methods. | Pakistan journal of pharmaceutical sciences 20120701 |
| Effects of anticholinesterase drugs on biomarkers and behavior of pumpkinseed, Lepomis gibbosus (Linnaeus, 1758). | Journal of environmental monitoring : JEM 20120501 |
| [Preparation and quality control of pyridostigmine bromide orally disintegrating tablet]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20120501 |
| A 90 year old man with difficulty swallowing and proximal muscle weakness. | BMJ (Clinical research ed.) 20120404 |
| A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned mice. | Basic & clinical pharmacology & toxicology 20120401 |
| Myasthenia gravis: a real emergency. | International emergency nursing 20120401 |
| Preparation and characterization of poly(lactic acid) nanoparticles for sustained release of pyridostigmine bromide. | Die Pharmazie 20120401 |
| A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. | Journal of neurology 20120301 |
| Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. | Leukemia & lymphoma 20120301 |
| Seronegative myasthenia gravis with bladder dysfunction. | Revue neurologique 20120301 |
| Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability. | Archives of pharmacal research 20120301 |
| Vincristine induced cranial neuropathy. | The Journal of the Association of Physicians of India 20120301 |
| Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation. | Journal of applied toxicology : JAT 20120201 |
| Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA). | Lupus 20120201 |
| Myasthenia gravis in Jamaican children: a 12-year institutional review. | Paediatrics and international child health 20120201 |
| Complex factors in the etiology of Gulf War illness: wartime exposures and risk factors in veteran subgroups. | Environmental health perspectives 20120101 |
| Delayed reduction of hippocampal synaptic transmission and spines following exposure to repeated subclinical doses of organophosphorus pesticide in adult mice. | Toxicological sciences : an official journal of the Society of Toxicology 20120101 |
| Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticides. | Journal of biochemical and molecular toxicology 20120101 |
| Anesthesia and myasthenia gravis. | Acta anaesthesiologica Scandinavica 20120101 |
| [+]-Huperzine A protects against soman toxicity in guinea pigs. | Neurochemical research 20111201 |
| Proteomic CNS profile of delayed cognitive impairment in mice exposed to Gulf War agents. | Neuromolecular medicine 20111201 |
| Discordant thymectomy in identical twins concordant for myasthenia gravis. | Annals of internal medicine 20111004 |
| Diagnosis of congenital myasthenic syndrome with mutation of the RAPSN gene after general anaesthesia. | European journal of anaesthesiology 20111001 |
| HIV-associated myasthenia gravis and impacts of HAART: one case report and a brief review. | Clinical neurology and neurosurgery 20111001 |
| Treatment of myasthenia gravis: focus on pyridostigmine. | Clinical drug investigation 20111001 |
| Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. | Journal of neurochemistry 20111001 |
| [Bioequivalence of pyridostigmine bromide dispersible tablets in rabbits]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111001 |
| In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species. | Toxicology letters 20110925 |
| Clinical profiles of Thai patients with ocular myasthenia gravis in Siriraj Hospital. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110901 |
| Chemical interactions and Gulf War illnesses. | Chemico-biological interactions 20110815 |
| Retention study of some cation-type compounds using bile acid sodium salts as ion pairing agents in liquid chromatography. | Biomedical chromatography : BMC 20110801 |
| Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. | Zeitschrift fur Gerontologie und Geriatrie 20110801 |
| Childhood myasthenia gravis: clinical features and outcomes. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110801 |
| Myasthenia gravis in a one year eight months old female child. | Journal of the Indian Medical Association 20110801 |
| Autoimmune autonomic ganglionopathy after a CNS infection. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20110601 |
| Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. | Pacing and clinical electrophysiology : PACE 20110601 |
| Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. | Neuromuscular disorders : NMD 20110601 |
| Myasthenia gravis as a cause of head drop in Parkinson disease. | The neurologist 20110501 |
| In vitro kinetic interactions of DEET, pyridostigmine and organophosphorus pesticides with human cholinesterases. | Chemico-biological interactions 20110425 |
| Delayed presentation of invasive thymoma in myasthenia gravis: a case report. | Neuromuscular disorders : NMD 20110401 |
| Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide. | Muscle & nerve 20110401 |
| Congenital myasthenic syndrome due to homozygous CHRNE mutations: report of patients in Arabia. | Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20110301 |
| Treatment for Lambert-Eaton myasthenic syndrome. | The Cochrane database of systematic reviews 20110216 |
| Antiarrhythmogenic effects of a neurotoxin from the spider Phoneutria nigriventer. | Toxicon : official journal of the International Society on Toxinology 20110201 |
| [Postural orthostatic tachycardia syndrome: current concepts in pathophysiology, diagnosis and therapeutic options]. | Fortschritte der Neurologie-Psychiatrie 20110201 |
| A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function. | The Journal of biological chemistry 20110128 |
| Congenital myasthenic syndrome: a case report. | Genetic counseling (Geneva, Switzerland) 20110101 |
| Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. | European journal of neurology 20101201 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Technical report: exploring the basis of congenital myasthenic syndromes in an undergraduate course, using the model organism, Caenorhabditis elegans. | Invertebrate neuroscience : IN 20101101 |
| Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial. | Clinical neurology and neurosurgery 20101101 |
| Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. | Hypertension (Dallas, Tex. : 1979) 20101101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Perspectives on the use of scopolamine as an adjunct treatment to enhance survival following organophosphorus nerve agent poisoning. | Military medicine 20101101 |
| Visual and systemic outcomes in pediatric ocular myasthenia gravis. | American journal of ophthalmology 20101001 |
| Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure. | Chemico-biological interactions 20100906 |
| Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice. | Neurotoxicology 20100901 |
| Diagnostic challenge: Myasthenia gravis in the emergency department. | Journal of the American Academy of Nurse Practitioners 20100901 |
| [Course and treatment of myasthenia gravis during pregnancy]. | Der Nervenarzt 20100801 |
| [Bizerine: new anticholinesterase drug with selective gastrointestinal action]. | Eksperimental'naia i klinicheskaia farmakologiia 20100801 |
| Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis. | Movement disorders : official journal of the Movement Disorder Society 20100715 |
| Gabapentin-induced exacerbation of myasthenia gravis. | Muscle & nerve 20100701 |
| Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. | Bioorganic & medicinal chemistry 20100701 |
| The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100601 |
| Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy. | Indian journal of pediatrics 20100601 |
| [Dysphagia as the sole manifestation of myasthenia gravis]. | Acta gastroenterologica Latinoamericana 20100601 |
| Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008). | Journal of the American Veterinary Medical Association 20100315 |
| Unsatisfactory outcomes in myasthenia gravis: influence by care providers. | Journal of neurology 20100301 |
| Rituximab in the management of refractory myasthenia gravis. | Muscle & nerve 20100301 |
| Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. | Critical care medicine 20100301 |
| Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications. | Bioorganic & medicinal chemistry letters 20100301 |
| Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20100201 |
| Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy. | Annals of physical and rehabilitation medicine 20100201 |
| Prolonged cardioprotective effect of pyridostigmine encapsulated in liposomes. | Life sciences 20100102 |
| Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. | Journal of molecular neuroscience : MN 20100101 |
| Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study. | Muscle & nerve 20100101 |
| Myasthenia gravis and return to flying status. | Aviation, space, and environmental medicine 20100101 |
| Autoimmune myasthenia gravis in a ferret. | Journal of the American Veterinary Medical Association 20091215 |
| Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. | Neurology 20091201 |
| Pyridostigmine, working and toxicity on platelet. | The Malaysian journal of pathology 20091201 |
| Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. | Behavioural brain research 20091105 |
| Teaching NeuroImages: reversible ectropion in myasthenia gravis. | Neurology 20091020 |
| Serum of patients with oral pemphigus vulgaris impairs keratinocyte wound repair in vitro: a time-lapse study on the efficacy of methylprednisolone and pyridostigmine bromide. | Oral diseases 20091001 |
| Management of myasthenic conditions: nonimmune issues. | Current opinion in neurology 20091001 |
| Retrospective population pharmacokinetic/pharmacodynamic analysis of pyridostigmine, a cholinesterase inhibitor, in Chinese males. | The Journal of pharmacy and pharmacology 20090901 |
| Association of preeclampsia and myasthenia: a case report. | The Journal of reproductive medicine 20090901 |
| Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20090801 |
| Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV. | AIDS research and human retroviruses 20090801 |
| Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. | Clinical pharmacology and therapeutics 20090701 |
| Congenital myasthenic syndrome with episodic apnea. | Pediatric neurology 20090701 |
| Decompensating esophoria as the presenting feature of myasthenia gravis. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20090601 |
| Vincristine induced unilateral ptosis. | Journal of pediatric hematology/oncology 20090601 |
| Effect of pyridostigmine (Mestinon) on human platelet aggregation. | The Malaysian journal of pathology 20090601 |
| Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. | Archives of neurology 20090501 |
| Pseudo plus-minus lid syndrome. | Archives of neurology 20090501 |
| Graded response to thymectomy in children with myasthenia gravis. | Journal of child neurology 20090401 |
| Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae. | Ecotoxicology and environmental safety 20090301 |
| The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. | Journal of clinical gastroenterology 20090301 |
| Why postprandial abdominal bloating in patients with irritable bowel syndrome does not respond to prokinetics. | The American journal of gastroenterology 20090301 |
| Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. | Journal of cardiac failure 20090301 |
| Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux! | Journal of critical care 20090301 |
| Terbutaline in myasthenia gravis: a pilot study. | Journal of the neurological sciences 20090215 |
| Repeated stress in combination with pyridostigmine Part I: long-term behavioural consequences. | Behavioural brain research 20090211 |
| Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions. | The Biochemical journal 20090101 |
| Membrane electrodes for the determination of pyridostigmine bromide. | Journal of AOAC International 20090101 |
| An unusual presentation of myasthenia gravis. | West African journal of medicine 20090101 |
| [Myasthenia gravis]. | La Revue du praticien 20081231 |
| Justice delayed: acknowledging the reality of Gulf War illness. | Lancet (London, England) 20081129 |
| Left ventricular long-axis function in myasthenia gravis. | Journal of neurology 20081101 |
| Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. | The American journal of gastroenterology 20081001 |
| Bradycardia, hypotension and bronchospasm following remifentanil-propofol in a myathenic paitent treated by pyridostigmine--a case report. | Middle East journal of anaesthesiology 20081001 |
| An unusual primary presentation of myasthenia gravis. | The British journal of oral & maxillofacial surgery 20080901 |
| Myasthenia gravis associated with lupus nephritis. | Lupus 20080901 |
| [Integrated traditional Chinese and Western medicine in treating 31 cases of myasthenia gravis]. | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20080901 |
| Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20080801 |
| Intestinal gas and bloating: effect of prokinetic stimulation. | The American journal of gastroenterology 20080801 |
| Long-term outcomes of pediatric ocular myasthenia gravis. | Ophthalmology 20080701 |
| Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20080601 |
| Myasthenia gravis associated with autoimmune thyroid disease: a report of two patients. | Annals of African medicine 20080601 |
| Cholinergic stimulation with pyridostigmine prevents the impairment in ventricular function during mental stress in coronary artery disease patients. | International journal of cardiology 20080425 |
| Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors. | Toxicology 20080418 |
| Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis. | Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20080401 |
| Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis. | Muscle & nerve 20080301 |
| Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy. | Paediatric anaesthesia 20080301 |
| In vitro metabolism and interactions of pyridostigmine bromide, N,N-diethyl-m-toluamide, and permethrin in human plasma and liver microsomal enzymes. | Xenobiotica; the fate of foreign compounds in biological systems 20080301 |
| Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis. | Journal of cardiovascular electrophysiology 20080201 |
| Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis. | Journal of neurology 20080201 |
| A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. | Arthritis and rheumatism 20080201 |
| Myasthenia gravis: an unrecognized cause of head drop in Parkinson's disease. | Parkinsonism & related disorders 20080101 |
| Myasthenia gravis crisis. | Southern medical journal 20080101 |
| A cause of reversible dysphagia: an unusual presentation of myasthenia gravis. | European journal of internal medicine 20080101 |
| [Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma]. | Revue neurologique 20080101 |
| Extended transsternal thymectomy for myasthenia gravis: a report of 19 consecutive cases. | Acta chirurgica Belgica 20080101 |
| Early onset myasthenia gravis with atypical features. | Kathmandu University medical journal (KUMJ) 20080101 |
| [Diagnostics and treatment of myasthenia gravis in children]. | Przeglad lekarski 20080101 |
| Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats. | Acta medica (Hradec Kralove) 20080101 |
| [Development of a myasthenia crisis during interferon treatment for chronic C hepatitis]. | Gastroenterologie clinique et biologique 20071201 |
| [Electroacupuncture warming therapy combined with western medicine for treatment of myasthenia gravis and effect on IL-4 level in the patients]. | Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20071201 |
| Treatment of botulinum toxin-induced eyelid ptosis with anticholinesterases. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20071101 |
| When the patient fails to respond to treatment: myasthenia gravis. | Practical neurology 20071101 |
| Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties. | Drug development and industrial pharmacy 20071101 |
| Latency and exposure-health associations in Gulf War veterans with early fatigue onsets: a case-control study. | Annals of epidemiology 20071001 |
| Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. | Pediatric hematology and oncology 20070901 |
| Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. | Neurology 20070821 |
| [Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070810 |
| Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome? | European journal of neurology 20070801 |
| Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy. | Pacing and clinical electrophysiology : PACE 20070801 |
| Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient. | Muscle & nerve 20070701 |
| Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes. | American journal of physiology. Heart and circulatory physiology 20070701 |
| Myasthenia gravis in ectopic thymoma presenting as pleural masses. | Lung cancer (Amsterdam, Netherlands) 20070701 |
| Post-varicella myasthenia gravis. | Singapore medical journal 20070601 |
| Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning. | Archives of toxicology 20070501 |
| A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise. | The Journal of rheumatology 20070501 |
| [Pyridostigmine in the treatment of primary orthostatic hypotension]. | Neurologia (Barcelona, Spain) 20070501 |
| An investigation of acetylcholine released in skeletal muscle and protein unbound drug released in blood based on the pyridostigmine bromide (pretreatment drug) sustained-release pellets by microdialysis technique in the rabbit model. | Neuroscience letters 20070418 |
| Effects of combined, multiple stressors on pyridostigmine-induced acute toxicity in rats. | Archives of toxicology 20070401 |
| Dropped head as an unusual presenting sign of myasthenia gravis. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20070401 |
| Concurrence of non-myasthenic symptoms with myasthenia gravis. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20070401 |
| Formulation design of a highly hygroscopic drug (pyridostigmine bromide) for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties. | Drug development and industrial pharmacy 20070401 |
| Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20070301 |
| Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine. | Toxicology and applied pharmacology 20070301 |
| Is there still a role for edrophonium in diagnosing ocular myasthenia. | European journal of neurology 20070301 |
| Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis. | Asian Pacific journal of allergy and immunology 20070301 |
| Myasthenia gravis mimicking unilateral vocal fold paralysis at presentation. | The Journal of laryngology and otology 20070201 |
| Pyridostigmine in the treatment of orthostatic intolerance. | The Annals of pharmacotherapy 20070201 |
| Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity. | Internal medicine journal 20070101 |
| Nerve agents. | The neurologist 20070101 |
| Effects of combined exposure to pyridostigmine bromide and shaker stress on acoustic startle response, pre-pulse inhibition and open field behavior in mice. | Journal of applied toxicology : JAT 20070101 |
| [Anesthesia with remifentanil for thoracoscopic thymectomy in a girl with myasthenia gravis]. | Revista espanola de anestesiologia y reanimacion 20070101 |
| Dropped head sign as the only symptom of myasthenia gravis. | Internal medicine (Tokyo, Japan) 20070101 |
| [Criminal clozapine intoxications]. | Anesteziologiia i reanimatologiia 20070101 |
| Myasthenia gravis and thymectomy: an anaesthetic approach. | Acta anaesthesiologica Belgica 20070101 |
| [Treatment of Lambert-Eaton syndrome with 3,4- diaminopyridine and pyridostigmine]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101 |
| An atypical course of myasthenia gravis. | Proceedings of the Western Pharmacology Society 20070101 |
| Development of methods to measure humoral immune responses against selected antigens in the common marmoset (Callithrix jacchus) and the effect of pyridostigmine bromide administration. | International immunopharmacology 20061205 |
| Multiple vaccine and pyridostigmine bromide interactions in the common marmoset Callithrix jacchus: immunological and endocrinological effects. | International immunopharmacology 20061205 |
| [Myasthenia gravis and intestinal resection: is dehiscence likely to occur?]. | Minerva chirurgica 20061201 |
| Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL. | Arhiv za higijenu rada i toksikologiju 20061201 |
| Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon. | Archives of toxicology 20061101 |
| Cerebral acetylcholine and choline contents and turnover following low-dose acetylcholinesterase inhibitors treatment in rats. | Archives of toxicology 20061101 |
| Pharmacokinetics of pyridostigmine in a child with postural tachycardia syndrome. | Pediatrics 20061101 |
| Coexistence of pernicious anemia and myasthenia gravis--a rare combination of autoimmune diseases in Taiwan. | Journal of the Formosan Medical Association = Taiwan yi zhi 20061101 |
| Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. | Gastroenterology 20061101 |
| [Bilateral paravertebral block anesthesia for thymectomy by video-assisted thoracoscopy in patients with myasthenia gravis]. | Revista espanola de anestesiologia y reanimacion 20061101 |
| Persistence of CD16+/CD56-/2B4+ natural killer cells: a highly dysfunctional NK subset expanded in ocular myasthenia gravis. | Journal of neuroimmunology 20061001 |
| Acetylcholinesterase inhibition in patients with orthostatic intolerance. | Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20061001 |
| Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. | Mayo Clinic proceedings 20061001 |
| Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine. | Basic & clinical pharmacology & toxicology 20061001 |
| Development of miotic cross-tolerance between pyridostigmine and sarin vapor. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061001 |
| A rare combination of thymic tumor: radiologically invisible thymolipoma associated with myasthenia gravis. | Neurology India 20060901 |
| Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. | Proceedings of the National Academy of Sciences of the United States of America 20060829 |
| Eosinophilia, myositis, and myasthenia gravis associated with a thymoma. | Muscle & nerve 20060801 |
| The 'slurp' test: bedside evaluation of bulbar muscle fatigue. | Pediatrics 20060801 |
| Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug? | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060801 |
| Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. | Biochemical pharmacology 20060728 |
| Available treatment options for the management of Lambert-Eaton myasthenic syndrome. | Expert opinion on pharmacotherapy 20060701 |
| Neuromyotonia and myasthenia gravis in the absence of thymoma. | European journal of neurology 20060701 |
| Cholinergic overstimulation supports conditioned-facilitated startle but not conditioned hyperalgesia. | Pharmacology, biochemistry, and behavior 20060701 |
| Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets. | Pharmacology, biochemistry, and behavior 20060601 |
| Dysphonia as first symptom of late-onset myasthenia gravis. | Journal of general internal medicine 20060601 |
| Vincristine induced cranial polyneuropathy. | Indian journal of pediatrics 20060601 |
| Multiple vaccine and pyridostigmine interactions: effects on EEG and sleep in the common marmoset. | Pharmacology, biochemistry, and behavior 20060601 |
| [Myasthenia gravis and hyperthyroidism: two cases]. | Annales d'endocrinologie 20060601 |
| Residual wires and autonomic failure treatment. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060601 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant. | Journal of toxicology and environmental health. Part A 20060501 |
| Myasthenia gravis accompanied with hypokalemic periodic paralysis. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060501 |
| Pyridostigmine treatment trial in neurogenic orthostatic hypotension. | Archives of neurology 20060401 |
| Fetal exposure to 3,4-diaminopyridine in a pregnant woman with congenital myasthenia syndrome. | The Annals of pharmacotherapy 20060401 |
| Acetylcholinesterase inhibition and orthostatic hypotension. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060401 |
| Childhood sexual abuse in relation to neurobiological challenge tests in patients with borderline personality disorder and normal controls. | Psychiatry research 20060330 |
| Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease. | International journal of cardiology 20060208 |
| [Stopping smoking and constipation]. | Presse medicale (Paris, France : 1983) 20060201 |
| Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. | Journal of applied toxicology : JAT 20060101 |
| [Ocular involvement in MuSK antibody-positive myasthenia gravis]. | Klinische Monatsblatter fur Augenheilkunde 20060101 |
| Rapid determination of N,N-diethyl-m-toluamide and permethrin in human plasma by gas chromatography-mass spectrometry and pyridostigmine bromide by high-performance liquid chromatography. | Journal of analytical toxicology 20060101 |
| Determination of pyridostigmine bromide and its metabolites in biological samples. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20060101 |
| Circadian rhythms of heart rate and locomotion after treatment with low-dose acetylcholinesterase inhibitors. | Journal of applied toxicology : JAT 20060101 |
| Myasthenia gravis disclosed by lithium carbonate. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| Intestinal pseudo-obstruction as initial presentation of thymoma. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20060101 |
| Acetylcholinesterase inhibition affects cardiovascular structure in mice. | Physiological research 20060101 |
| Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. | Chemico-biological interactions 20051215 |
| Bioscavengers for the protection of humans against organophosphate toxicity. | Chemico-biological interactions 20051215 |
| Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity. | Chemico-biological interactions 20051215 |
| An ex vivo approach for the evaluation of reversible inhibitors as potential pretreatments against organophosphate toxicity. | Chemico-biological interactions 20051215 |
| Pyridostigmine in the treatment of orthostatic hypotension. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20051201 |
| Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. | Neurology 20051108 |
| Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome. | The Journal of clinical endocrinology and metabolism 20051001 |
| Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. | The British journal of ophthalmology 20051001 |
| An elderly man with dysphagia and dysarthria. | Indian journal of medical sciences 20051001 |
| Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis. | International journal of cardiology 20050901 |
| Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. | Neurology 20050823 |
| Mild interoceptive stressors affect learning and reactivity to contextual cues: toward understanding the development of unexplained illnesses. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050801 |
| Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. | Circulation 20050531 |
| Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion. | Clinical endocrinology 20050501 |
| Vaccination alone or in combination with pyridostigmine promotes and prolongs activation of stress-activated kinases induced by stress in the mouse brain. | Journal of neurochemistry 20050501 |
| Off-label administration of drugs to healthy military personnel. Dubious ethics of preventive measures. | Journal of medical ethics 20050501 |
| Low-dose cholinesterase inhibitors do not induce delayed effects on cerebral blood flow and metabolism. | Pharmacology, biochemistry, and behavior 20050401 |
| Treatment counters low blood pressure upon standing. | Mayo Clinic health letter (English ed.) 20050401 |
| Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments. | Neuroscience letters 20050307 |
| A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model. | International immunopharmacology 20050301 |
| Pharmacologic prophylaxis against nerve agent poisoning. | The Israel Medical Association journal : IMAJ 20050301 |
| Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation. | Neurochemical research 20050301 |
| Myasthenia gravis and a rare complication of chemotherapy. | The Medical journal of Australia 20050207 |
| The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components. | Neurobiology of disease 20050201 |
| Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20050201 |
| Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine's association with Gulf War syndrome? | Medical hypotheses 20050101 |
| Diagnosis of growth hormone deficiency. | Frontiers of hormone research 20050101 |
| [The influence of aminostigmine on the parameters of nonspecific resistance and immune system of the organism upon acute poisoning of benzyl 3-quinuclidylate]. | Eksperimental'naia i klinicheskaia farmakologiia 20050101 |
| Old legacies and new paradigms: confusing 'research' and 'treatment' and its consequences in responding to emergent health threats. | Journal of health care law & policy 20050101 |
| Statin-associated exacerbation of myasthenia gravis. | Neurology 20041214 |
| Cardiac responses of Pacific oyster Crassostrea gigas to agents modulating cholinergic function. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20041201 |
| New treatment eyed for low blood pressure. | Harvard heart letter : from Harvard Medical School 20041201 |
| An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function. | International immunopharmacology 20041101 |
| Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. | Heart (British Cardiac Society) 20041001 |
| Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. | American journal of hematology 20041001 |
| Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs. | Nuclear medicine and biology 20041001 |
| Minimally invasive gastric bypass in a morbidly obese patient with myasthenia gravis. | Obesity surgery 20041001 |
| Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. | Anaesthesia and intensive care 20041001 |
| Pulmonary metastasis 12 years after resection of thymoma with microscopic capsule invasion. | Japanese journal of clinical oncology 20041001 |
| The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. | The Journal of clinical endocrinology and metabolism 20040901 |
| Sick veterans pin hopes on Gulf War inquiry. | Nature 20040819 |
| Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice. | American journal of physiology. Heart and circulatory physiology 20040701 |
| Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. | Autonomic neuroscience : basic & clinical 20040630 |
| Distinct phenotypes of congenital acetylcholine receptor deficiency. | Neuromuscular disorders : NMD 20040601 |
| Acetylcholine regulates ghrelin secretion in humans. | The Journal of clinical endocrinology and metabolism 20040501 |
| Therapy for nerve agent poisoning. | Archives of neurology 20040501 |
| Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity. | Toxicological sciences : an official journal of the Society of Toxicology 20040401 |
| [Acute respiratory failure that needs mechanical ventilation: first manifestation of myasthenia gravis]. | Anales de medicina interna (Madrid, Spain : 1984) 20040401 |
| Persistent/delayed toxic effects of low-dose sarin and pyridostigmine under physical stress (exercise) in mice. | Indian journal of physiology and pharmacology 20040401 |
| Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis. | Neurology 20040309 |
| Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. | Pediatric blood & cancer 20040301 |
| Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. | Clinical endocrinology 20040301 |
| Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. | Archives of dermatology 20040301 |
| Congenital myasthenic syndrome: presentation, electrodiagnosis, and muscle biopsy. | Journal of child neurology 20040301 |
| Acute experimental tabun-induced intoxication and its therapy in rats. | Central European journal of public health 20040301 |
| Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease? | Journal of the neurological sciences 20040215 |
| The effect of prednisone on the progression from ocular to generalized myasthenia gravis. | Journal of the neurological sciences 20040215 |
| Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. | Pharmacology, biochemistry, and behavior 20040201 |
| Lambert-Eaton myasthenic syndrome. | Revue neurologique 20040201 |
| Effects of fosphenytoin on nerve agent-induced status epilepticus. | Drug and chemical toxicology 20040201 |
| Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. | Immunopharmacology and immunotoxicology 20040201 |
| Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum. | Journal of toxicology and environmental health. Part A 20040123 |
| Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. | Psychiatry research 20040101 |
| Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis. | Journal of applied toxicology : JAT 20040101 |
| New approaches to the treatment of pemphigus. | The journal of investigative dermatology. Symposium proceedings 20040101 |
| Acute neuromuscular failure related to long-term botulinum toxin therapy. | European neurology 20040101 |
| Myasthenia gravis: an unusual cause of diplopia in polymyalgia rheumatica. | Clinical and experimental rheumatology 20040101 |
| Low levels of sarin affect the EEG in marmoset monkeys: a pilot study. | Journal of applied toxicology : JAT 20040101 |
| Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement. | Journal of neurology, neurosurgery, and psychiatry 20031201 |
| Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of pyridostigmine bromide from guinea pig plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031105 |
| Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats. | Archives of toxicology 20031001 |
| Acetylcholinesterase inhibition in the treatment of hypotension. | Journal of neurology, neurosurgery, and psychiatry 20030901 |
| Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. | Journal of neurology, neurosurgery, and psychiatry 20030901 |
| Heart rate variability in chronic heart failure: target for therapy? | American heart journal 20030901 |
| Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. | American heart journal 20030901 |
| Unilateral headache due to myasthenia gravis. | Cephalalgia : an international journal of headache 20030901 |
| Combined forced running stress and subclinical paraoxon exposure have little effect on pyridostigmine-induced acute toxicity in rats. | Toxicology 20030828 |
| Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. | Clinical science (London, England : 1979) 20030801 |
| Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. | Heart (British Cardiac Society) 20030801 |
| Childhood ocular myasthenia gravis. | Ophthalmology 20030701 |
| Comparative efficacy of diazepam and avizafone against sarin-induced neuropathology and respiratory failure in guinea pigs: influence of atropine dose. | Toxicology 20030630 |
| Gulf War syndrome revisited. | EMBO reports 20030601 |
| Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium. | The Annals of thoracic surgery 20030601 |
| Myasthenia gravis and masticatory muscle myositis in a dog. | The Canadian veterinary journal = La revue veterinaire canadienne 20030601 |
| Parkinson's disease associated with myasthenia gravis. A report of 4 cases. | Journal of neurology 20030601 |
| Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa. | Journal of endocrinological investigation 20030601 |
| Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects. | Life sciences 20030523 |
| Take your pyridostigmine: that's an (ethical?) order! | The Lancet. Neurology 20030501 |
| Control of nerve agent-induced seizures is critical for neuroprotection and survival. | Toxicology and applied pharmacology 20030415 |
| Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. | Clinical endocrinology 20030401 |
| Changes in respiratory condition after thymectomy for patients with myasthenia gravis. | Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20030401 |
| Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats. | Toxicology 20030314 |
| Clinical trials. New rule triggers debate over best way to test drugs. | Science (New York, N.Y.) 20030314 |
| Thymectomy in ocular myasthenia gravis. | The Journal of thoracic and cardiovascular surgery 20030301 |
| Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. | Pharmacology, biochemistry, and behavior 20030301 |
| Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin. | Toxicology 20030201 |
| [Ogilvie's syndrome: a rare cause of the acute abdomen]. | Zeitschrift fur Gastroenterologie 20030201 |
| Pyridostigmine enhances glutamatergic transmission in hippocampal CA1 neurons. | Experimental neurology 20030201 |
| Impact of growth hormone on central nervous activity, vigilance, and tiredness after short-term therapy in growth hormone-deficient adults. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20030201 |
| Percutaneous absorption of topical N,N-diethyl-m-toluamide (DEET): effects of exposure variables and coadministered toxicants. | Journal of toxicology and environmental health. Part A 20030124 |
| Testicular germ-cell apoptosis in stressed rats following combined exposure to pyridostigmine bromide, N,N-diethyl m-toluamide (DEET), and permethrin. | Journal of toxicology and environmental health. Part A 20030110 |
| Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women. | Psychoneuroendocrinology 20030101 |
| Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. | The Journal of pharmacology and experimental therapeutics 20030101 |
| Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. | Clinical endocrinology 20030101 |
| Pyridostigmine for fibromyalgia: comment on the article by Paiva and a historical vignette. | Arthritis and rheumatism 20030101 |
| Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. | European neurology 20030101 |
| Double trouble. | Survey of ophthalmology 20030101 |
| Heightening awareness of myasthenia gravis, its presentation, symptoms and new treatments that are now available. | Journal of the Irish Dental Association 20030101 |
| A comparison of the neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats. | Acta medica (Hradec Kralove) 20030101 |
| Effect of methoxime combined with anticholinergic, anticonvulsant or anti-HCN drugs in tabun-poisoned mice. | Acta medica (Hradec Kralove) 20030101 |
| The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. | Journal of postgraduate medicine 20030101 |
| A typical case of Myasthenia Gravis. | Kathmandu University medical journal (KUMJ) 20030101 |
| Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis. | Clinical neurology and neurosurgery 20021201 |
| Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. | Anesthesia and analgesia 20021201 |
| Autosomal recessive limb girdle myasthenia in two sisters. | Neurology India 20021201 |
| Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. | Environmental health perspectives 20021201 |
| Myasthenia mimicking vertebrobasilar stroke. | Journal of neurology 20021101 |
| In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes. | Journal of the neurological sciences 20021015 |
| Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors. | Anesthesia and analgesia 20020901 |
| Complete inhibition of hypothalamic somatostatin activity is only partially responsible for the growth hormone response to strenuous exercise. | Metabolism: clinical and experimental 20020901 |
| Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. | Toxicological sciences : an official journal of the Society of Toxicology 20020901 |
| Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig. | Neurotoxicology 20020901 |
| Preparation and in vitro evaluation of pyridostigmine bromide microparticles. | International journal of pharmaceutics 20020821 |
| A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. | Toxicology 20020815 |
| Myasthenia gravis in pregnancy: report on 69 cases. | European journal of obstetrics, gynecology, and reproductive biology 20020805 |
| Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin. Alone and in combination. | Toxicological sciences : an official journal of the Society of Toxicology 20020801 |
| Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. | Drug and chemical toxicology 20020801 |
| Altered hypothalamic cholinergic responses in patients with nonulcer dyspepsia: a study of pyridostigmine-stimulated growth hormone release. | The American journal of gastroenterology 20020801 |
| Neither forced running nor forced swimming affect acute pyridostigmine toxicity or brain-regional cholinesterase inhibition in rats. | Toxicology 20020701 |
| Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis. | Anesthesia and analgesia 20020701 |
| Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. | Psychopharmacology 20020701 |
| Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis. | Muscle & nerve 20020701 |
| [Ptosis and mastication disorders revealing concurrent myasthenia gravis and chronic polyradiculoneuritis]. | Revue neurologique 20020701 |
| Pyridostigmine bromide modulates the dermal disposition of [14C]permethrin. | Toxicology and applied pharmacology 20020615 |
| [Growth disorders in Down's syndrome: growth hormone treatment]. | Minerva endocrinologica 20020601 |
| Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020601 |
| Pyridostigmine bromide and the long-term subjective health status of a sample of over 700 male Reserve Component Gulf War era veterans. | Psychological reports 20020601 |
| Actions of pyridostigmine and organophosphate agents on chick cells, mice, and chickens. | Drug and chemical toxicology 20020501 |
| Binding of pyridostigmine bromide, N,N-diethyl-m-toluamide and permethrin, alone and in combinations, to human serum albumin. | Archives of toxicology 20020501 |
| Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. | Arthritis and rheumatism 20020501 |
| In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide. | Drug metabolism and disposition: the biological fate of chemicals 20020301 |
| Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats. | Toxicological sciences : an official journal of the Society of Toxicology 20020301 |
| Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa. | Clinical endocrinology 20020301 |
| Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors. | Journal of medicinal chemistry 20020214 |
| Peripheral cholinergic pathway modulates hyperthermia induced by stress in rats exposed to open-field stress. | Journal of applied physiology (Bethesda, Md. : 1985) 20020201 |
| Presentation of myasthenia gravis mimicking blepharospasm. | Neurology 20020108 |
| Prevention and treatment of injury from chemical warfare agents. | The Medical letter on drugs and therapeutics 20020107 |
| The use of the pyridostigmine growth hormone-releasing hormone stimulation test to detect growth hormone deficiency in patients with pituitary adenomas. | Metabolism: clinical and experimental 20020101 |
| Ocular myasthenia presenting as progressive external ophthalmoplegia. | Journal of pediatric ophthalmology and strabismus 20020101 |
| Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases. | Binocular vision & strabismus quarterly 20020101 |
| Cardiorespiratory effects following acute exposure to pyridostigmine bromide and/or N,N-diethyl-m-toluamide (DEET) in rats. | International journal of toxicology 20020101 |
| [Respiratory arrests caused by congenital myasthenia gravis syndrome]. | Duodecim; laaketieteellinen aikakauskirja 20020101 |
| Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. | Journal of capillary electrophoresis and microchip technology 20020101 |
| A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine. | Journal of pharmaceutical and biomedical analysis 20011201 |
| Effects of contralateral white noise stimulation on distortion product otoacoustic emissions in myasthenic patients. | Hearing research 20011201 |
| Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition. | Aviation, space, and environmental medicine 20011201 |
| The effect of continuous pyridostigmine administration on functional (A12) acetylcholinesterase activity in guinea-pig muscles. | Neurotoxicology 20011201 |
| Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. | Liver 20011201 |
| Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. | Journal of applied toxicology : JAT 20011201 |
| Reactive oxygen species mediate pyridostigmine-induced neuronal apoptosis: involvement of muscarinic and NMDA receptors. | Toxicology and applied pharmacology 20011115 |
| Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels. | The Journal of clinical endocrinology and metabolism 20011101 |
| Determination of depleted uranium, pyridostigmine bromide and its metabolite in plasma and urine following combined administration in rats. | Journal of pharmaceutical and biomedical analysis 20010901 |
| The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion. | Environmental toxicology and chemistry 20010901 |
| Electroplegia: an alternative to blood cardioplegia for arresting the heart during conventional (on-pump) cardiac operation. | The Annals of thoracic surgery 20010901 |
| Myasthenia gravis in children: analysis of 18 patients. | Arquivos de neuro-psiquiatria 20010901 |
| Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrotyrosine and 8-hydroxy-2'-deoxyguanosine, biomarkers of oxidative stress. | Toxicology letters 20010806 |
| High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine. | Journal of chromatographic science 20010701 |
| Pyridostigmine-induced microcephaly. | Neurology 20010612 |
| Pyridostigmine-induced microcephaly. | Neurology 20010612 |
| Evaluation of immunotoxicity induced by single or concurrent exposure to N,N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel. | Toxicology and industrial health 20010601 |
| Myasthenia gravis with autoimmune autonomic neuropathy. | Autonomic neuroscience : basic & clinical 20010514 |
| Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability. | Drug and chemical toxicology 20010501 |
| Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity. | Drug and chemical toxicology 20010501 |
| Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome. | Journal of endocrinological investigation 20010501 |
| Induction of urinary excretion of 3-nitrotyrosine, a marker of oxidative stress, following administration of pyridostigmine bromide, DEET (N,N-diethyl-m-toluamide) and permethrin, alone and in combination in rats. | Toxicology letters 20010430 |
| Chromatographic method for the determination of diazepam, pyridostigmine bromide, and their metabolites in rat plasma and urine. | Journal of chromatography. B, Biomedical sciences and applications 20010425 |
| Development of a high-performance liquid chromatographic method for the quantification of chlorpyrifos, pyridostigmine bromide, N,N-diethyl-m-toluamide and their metabolites in rat plasma and urine. | Journal of chromatography. B, Biomedical sciences and applications 20010425 |
| Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. | Toxicological sciences : an official journal of the Society of Toxicology 20010401 |
| Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experience. | Journal of the American College of Surgeons 20010401 |
| Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine. | Arquivos brasileiros de cardiologia 20010401 |
| Familial autoimmune myasthenia gravis. | Singapore medical journal 20010401 |
| Cocaine abuse, generalized myasthenia, complete external ophthalmoplegia, and pseudotonic pupil. | Strabismus 20010301 |
| Central nervous system effects from a peripherally acting cholinesterase inhibiting agent: interaction with stress or genetics. | Annals of the New York Academy of Sciences 20010301 |
| Laryngeal myasthenia gravis: report of 40 cases. | Journal of voice : official journal of the Voice Foundation 20010301 |
| Pyridostigmine bromide and the long-term subjective health status of a sample of female reserve component Gulf War veterans: a brief report. | Psychological reports 20010201 |
| Perioperative management of a patient with congenital myasthenia gravis for elective caesarean section. | Singapore medical journal 20010201 |
| Many Gulf War illnesses may be autoimmune disorders caused by the chemical and biological stressors pyridostigmine bromide, and adrenaline. | Medical hypotheses 20010201 |
| Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20010201 |
| Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors. | Life sciences 20010119 |
| A dose-response study of anticholinesterase drugs on contractile and phosphatidylinositol responses of rat trachea. | Anesthesia and analgesia 20010101 |
| Biological consequences of multiple vaccine and pyridostigmine pretreatment in the guinea pig. | Journal of applied toxicology : JAT 20010101 |
| Bulbar presentations of myasthenia gravis in the elderly patient. | The Journal of laryngology and otology 20010101 |
| The effects of pyridostigmine bromide on progressive ratio performance in male and female rats. | Pharmacology, biochemistry, and behavior 20010101 |
| The role of cholinergic transmission in outer hair cell functioning evaluated by distortion product otoacoustic emissions in myasthenic patients. | Acta oto-laryngologica 20010101 |
| The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis. | Clinical neuropharmacology 20010101 |
| The effects of pyridostigmine bromide, permethrin, and DEET alone, or in combination, on fixed-ratio and fixed-interval behavior in male and female rats. | Pharmacology, biochemistry, and behavior 20010101 |
| Interaction of pyridostigmine and physical stress on antioxidant defense system in skeletal muscle of mice. | Journal of applied toxicology : JAT 20010101 |
| [Myasthenia gravis associated with HIV infection]. | Ryoikibetsu shokogun shirizu 20010101 |
| The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. | Pharmacology, biochemistry, and behavior 20010101 |
| Prognostic factors of thymectomy in patients with myasthenia gravis: a cohort of 132 patients. | European neurology 20010101 |
| Neurotoxicology of the brain barrier system: new implications. | Journal of toxicology. Clinical toxicology 20010101 |
| Ritonavir-associated myasthenia gravis. | Muscle & nerve 19980501 |
| [Myasthenic crisis caused by azathioprine-induced fever]. | Der Nervenarzt 19970401 |
| Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. | The Journal of clinical endocrinology and metabolism 19960301 |
| Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. | The Journal of clinical endocrinology and metabolism 19960301 |
| Myasthenia gravis and levonorgestrel implant. | Lancet (London, England) 19951209 |
| Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine. | European journal of haematology 19950801 |
| D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence? | Clinical rheumatology 19941201 |
| [D-penicillamine-induced myasthenia gravis]. | Schweizerische medizinische Wochenschrift 19940521 |
| Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog. | The Journal of endocrinology 19930801 |
| Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. | The Journal of clinical endocrinology and metabolism 19930401 |
| [A comparison of the two anticholinergic agents atropine and glycopyrrolate during antagonism of a muscle relaxation with pyridostigmine]. | Anaesthesiologie und Reanimation 19930101 |
| Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. | The Journal of clinical endocrinology and metabolism 19930101 |
| Myasthenia gravis presenting as weakness after magnesium administration. | Muscle & nerve 19900801 |
| Long term treatment of myasthenia gravis with azathioprine. | Postgraduate medical journal 19900201 |
| Prolonged paralysis associated with long-term pancuronium use. | Pharmacotherapy 19890101 |
| Parkinsonism induced by pyridostigmine. | Acta neurologica Scandinavica 19880901 |
| [Acetylcholine receptor antibody in D-penicillamine therapy]. | Zeitschrift fur Rheumatologie 19860101 |
| [Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine]. | Der Anaesthesist 19841001 |
| Penicillamine induced myasthenia reactivated by gold. | British medical journal (Clinical research ed.) 19840121 |
| [Myasthenic syndrome--complication of D-penicillamine therapy]. | Zeitschrift fur arztliche Fortbildung 19840101 |
| D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis. | Gastroenterology 19840101 |
| [Myasthenia syndrome during chloroquine treatment (author's transl)]. | Deutsche medizinische Wochenschrift (1946) 19811225 |
| Myasthenia gravis and penicillamine therapy of rheumatoid arthritis. | JAMA 19801017 |
| Timolol and myasthenia gravis. | JAMA 19791012 |
| [A myasthenic reaction provoked by lithium carbonate treatment]. | Ugeskrift for laeger 19780925 |
| [Myasthenia syndrome after peroral treatment with penicillamine]. | Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 19780101 |
| D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis. | Annals of internal medicine 19771101 |
| Cardiac arrest and arrhythmias due to self-poisoning with imipramine. | Anaesthesia 19690101 |
© 2019 Angene International Limited. All rights Reserved.